Claims for Patent: 8,895,756

Summary for Patent: 8,895,756

Title:	Bendamustine pharmaceutical compositions
Abstract:	The present invention provides pharmaceutical formulations of lyophilized bendamustine suitable for pharmaceutical use. The present invention further provides methods of producing lyophilized bendamustine. The pharmaceutical formulations can be used for any disease that is sensitive to treatment with bendamustine, such as neoplastic diseases.
Inventor(s):	Brittain; Jason Edward (El Cajon, CA), Franklin; Joe Craig (Tulsa, OK)
Assignee:	Cephalon, Inc. (Frazer, PA)
Application Number:	13/719,409
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,895,756
Patent Claims:	1. A vial containing a reconstituted solution of bendamustine hydrochloride and mannitol in sterile water for injection, wherein the ratio by weight of bendamustine hydrochloride to mannitol in the vial is 15:25.5, and wherein the bendamustine hydrochloride is present in the vial at a concentration of 100 mg per 20 mL. 2. The vial of claim 1, wherein the vial contains 25 mg of bendamustine hydrochloride. 3. The vial of claim 1, wherein the vial contains 100 mg of bendamustine hydrochloride. 4. A 20 mL vial containing 100 mg of bendamustine hydrochloride and 170 mg of mannitol reconstituted in sterile water for injection.